Cargando…
A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses
In 2020 and 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, caused a global pandemic. Vaccines are expected to reduce the pressure of prevention and control, and have become the most effective strategy to solve the pandemic crisis. SARS-CoV-2 infects the host...
Autores principales: | Liu, Bo, Yin, Ying, Liu, Yuxiao, Wang, Tiantian, Sun, Peng, Ou, Yangqin, Gong, Xin, Hou, Xuchen, Zhang, Jun, Ren, Hongguang, Luo, Shiqiang, Ke, Qian, Yao, Yongming, Xu, Junjie, Wu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378774/ https://www.ncbi.nlm.nih.gov/pubmed/34457370 http://dx.doi.org/10.1016/j.eng.2021.06.012 |
Ejemplares similares
-
Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants
por: Mi, Taotao, et al.
Publicado: (2022) -
Fed-batch fermentation of GM-CSF-producing glycoengineered Pichia pastoris under controlled specific growth rate
por: Jacobs, Pieter P, et al.
Publicado: (2010) -
A bivalent subunit vaccine efficiently produced in Pichia pastoris against SARS-CoV-2 and emerging variants
por: Xu, Huifang, et al.
Publicado: (2023) -
Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris
por: Chuck, Chi-Pang, et al.
Publicado: (2008) -
Expression, purification and biological characterization of the extracellular domain of CD40 from Pichia pastoris
por: Zhan, Yu, et al.
Publicado: (2016)